Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Critical role of growth medium for detecting drug interactions in Gram-negative bacteria that model in vivo responses

mBio(2024)10.1128/mbio.00159-24Source: DataRank Database

Critical role of growth medium for detecting drug interactions in Gram-negative bacteria that model in vivo responses is a research paper published in mBio (2024). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 1.53)OA: goldTopics (44)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Yoelkys Morales ORCID,Rachel Ende ORCID,Ryan Peters,Anne L. McCabe ORCID,Joan Mecsas ORCID

Live enrichment

PubMed:38364199 OpenAlex:https://openalex.org/W4391875826

HHS | NIH | National Institute of Allergy and Infectious Diseases

Grant: U1914270

HHS | NIH | National Institute of General Medical Sciences

Grant: 1K12GM133314

HHS | NIH | National Institute of Allergy and Infectious Diseases

Grant: 4T32AI007422

HHS | NIH | National Institute of Allergy and Infectious Diseases

Grant: AI169786

NIGMS NIH HHS

Grant: K12 GM133314

NIAID NIH HHS

Grant: R01 AI169786

NIAID NIH HHS

Grant: T32 AI007422

NIGMS NIH HHS

Grant: T32 GM146621

FWCI

1.53

Citation Percentile

0.8%

Citation Trend

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1128/mbio.00159-24

publisherhttps://doi.org/10.1128/mbio.00159-24

publisherhttps://journals.asm.org/doi/pdf/10.1128/mbio.00159-24

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38364199

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10936441

Fields of Study

Antibiotic Resistance in BacteriaAntibiotics Pharmacokinetics and EfficacyAntibiotic Use and ResistanceMiceAnimalsAnti-Bacterial AgentsGram-Negative BacteriaDrug Resistance, Multiple, BacterialDrug InteractionsKlebsiella pneumoniaeDrug CombinationsMicrobial Sensitivity TestsPseudomonas aeruginosa

MeSH Terms

AnimalsAnti-Bacterial AgentsDrug CombinationsDrug InteractionsGram-Negative BacteriaKlebsiella pneumoniaeMicrobial Sensitivity TestsPseudomonas aeruginosaDrug Resistance, Multiple, BacterialMice

Keywords

Acinetobacter baumanniiIn vivoPseudomonas aeruginosaAntibioticsMicrobiologyIn vitroKlebsiella pneumoniaeBacteriaBacterial growthBiologyDrugDrug resistanceGram-negative bacteriaPharmacologyEscherichia coliBiotechnologyBiochemistryAcinetobacterKlebsiellaantibiotic resistancecombination therapy

Sustainable Development Goals

SDG 0: Good health and well-being